More California biotechs attract Japanese drugmakers

12/28/2009 | Los Angeles Times (tiered subscription model)

A growing number of Japanese companies are teaming up with biotech firms in California to discover and market new treatments. Japanese drug firms consistently look for a "consensus-based arrangement" that is very different from Western companies' approach to development deals, said Patrick Machado, chief financial officer of Medivation, which recently signed a pact with Astellas Pharma for a prostate cancer drug.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ